Skip to content

SCHEDULE 13G/AAccepted Feb 6, 4:32 PM ET

Maze Therapeutics, Inc. SCHEDULE 13G/A

GV 2019, L.P.

sec.gov(opens the filing on sec.gov)

Accepted (ET)

4:32 PM

Feb 6, 2026

Filed

Feb 6, 2026

Documents

1

Size

21.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.